BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29381046)

  • 1. A Cleavage-Responsive Stem-Loop Hairpin for Assaying Guide RNA Activity.
    deBoer TR; Wauford N; Chung JY; Torres Perez MS; Murthy N
    ACS Chem Biol; 2018 Feb; 13(2):461-466. PubMed ID: 29381046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance.
    Babu K; Amrani N; Jiang W; Yogesha SD; Nguyen R; Qin PZ; Rajan R
    Biochemistry; 2019 Apr; 58(14):1905-1917. PubMed ID: 30916546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for Measuring CRISPR/Cas9 DNA Cleavage in Cells.
    Cromwell CR; Jovel J; Hubbard BP
    Methods Mol Biol; 2021; 2162():197-213. PubMed ID: 32926384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage.
    Parameshwaran HP; Babu K; Tran C; Guan K; Allen A; Kathiresan V; Qin PZ; Rajan R
    FEBS Lett; 2021 Apr; 595(7):892-912. PubMed ID: 33523494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Versatile 3' Functionalization of CRISPR Single Guide RNA.
    Palumbo CM; Gutierrez-Bujari JM; O'Geen H; Segal DJ; Beal PA
    Chembiochem; 2020 Jun; 21(11):1633-1640. PubMed ID: 31943634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Guide RNA Design Guidelines for Efficient Genome Editing.
    Schindele P; Wolter F; Puchta H
    Methods Mol Biol; 2020; 2166():331-342. PubMed ID: 32710418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
    Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5' modifications to CRISPR-Cas9 gRNA can change the dynamics and size of R-loops and inhibit DNA cleavage.
    Mullally G; van Aelst K; Naqvi MM; Diffin FM; Karvelis T; Gasiunas G; Siksnys V; Szczelkun MD
    Nucleic Acids Res; 2020 Jul; 48(12):6811-6823. PubMed ID: 32496535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.
    Anders C; Niewoehner O; Jinek M
    Methods Enzymol; 2015; 558():515-537. PubMed ID: 26068752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
    Briner AE; Henriksen ED; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A G-quadruplex motif at the 3' end of sgRNAs improves CRISPR-Cas9 based genome editing efficiency.
    Nahar S; Sehgal P; Azhar M; Rai M; Singh A; Sivasubbu S; Chakraborty D; Maiti S
    Chem Commun (Camb); 2018 Mar; 54(19):2377-2380. PubMed ID: 29450416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro enzymology of Cas9.
    Anders C; Jinek M
    Methods Enzymol; 2014; 546():1-20. PubMed ID: 25398333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.